- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Deferasirox – July 2015
Deferasirox; 125 mg dispersible tablet, 28; 250 mg dispersible tablet, 28; 500mg dispersible tablet, 28; Exjade®
Last updated
1 November 2015